RESUMEN
BACKGROUND: Incorporation of new rotavirus vaccines into national programs of developing countries will rely on well-designed cost-effective analysis based on accurate assessment of disease burden. For Chile, rotavirus disease burden is determined mostly by outpatient clinic and emergency room visits and by hospitalizations. We previously estimated a yearly incidence of 8000 and 53,000 hospitalizations and emergency room visits respectively for children Asunto(s)
Instituciones de Atención Ambulatoria/estadística & datos numéricos
, Infecciones por Rotavirus/epidemiología
, Rotavirus/aislamiento & purificación
, Preescolar
, Chile/epidemiología
, Femenino
, Humanos
, Lactante
, Masculino
, Vigilancia de la Población/métodos
, Estudios Prospectivos
, Serotipificación/métodos